Associations of Serum Alpha-Linolenic Acid with Disability and Brain Volume in Multiple Sclerosis: A Concise Replication Study - Top-Institutions - MDSpire

Associations of Serum Alpha-Linolenic Acid with Disability and Brain Volume in Multiple Sclerosis: A Concise Replication Study

  • By

  • Max Korbmacher

  • Kjell-Morten Myhr

  • Stig Wergeland

  • Kristin Wesnes

  • Øivind Torkildsen

  • April 27, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology
    • Neuroimaging

  • #2

    University of California, San Francisco (UCSF) Multiple Sclerosis Center
    University of California, San Francisco (UCSF) Multiple Sclerosis Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology
    • Neuroimaging

  • #3

    University of Oxford, Nuffield Department of Clinical Neurosciences
    University of Oxford, Nuffield Department of Clinical Neurosciences

    Oxford, Oxfordshire

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology
    • Neuroimaging

  • #4

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Stockholm County

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology
    • Neuroimaging

  • #5

    University of California, Los Angeles (UCLA) Multiple Sclerosis Program
    University of California, Los Angeles (UCLA) Multiple Sclerosis Program

    Los Angeles, CA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology
    • Neuroimaging

Original Source(s)

Associations of Serum Alpha-Linolenic Acid with Disability and Brain Volume in Multiple Sclerosis: A Concise Replication Study

  • by Max Korbmacher, Kjell-Morten Myhr, Stig Wergeland, Kristin Wesnes, Øivind Torkildsen

  • April 27, 2026

Related Content

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis

Listening to MS: AI-assisted speech analysis for diagnosis and fatigue prediction (COMMITMENT)

Hippocampal neuronal hypoexcitability contributes to PTSD-like phenotypes in the experimental autoimmune encephalomyelitis model